Neuropsychiatric symptoms among patients with long COVID

More than two years after the COVID-19 pandemic erupted, scientists have become increasingly aware of a group of patients -; so-called 'long haulers' -; who remain plagued by a combination of symptoms long after the infection passes. In a study published in the Journal of Clinical Neuroscience, specialists from Massachusetts General Hospital (MGH) describe their findings related to their multidisciplinary clinical work in this area.

Commonly, patients with long COVID present with 'brain fog', a vague description including lack of sleep, anxiety, depression and a history of headache or migraine combined with trouble with attention and word finding difficulties as well as executive dysfunction. In the patients we treated with long COVID who presented with "brain fog" we found that the root cause of this commonly used term is often multifactorial."

Zeina Chemali, MD, MPH, Director, Neuropsychiatry Clinics and Training at MGH, and medical director of the McCance Center for Brain Health

In their study conducted over 15 months from February 2020-May 2021, Chemali and colleagues followed 87 confirmed and 13 presumed cases of non-hospitalized individuals with lasting symptoms beyond six months after COVID-19 infection.

A key feature of the study is that most (75%) of the cohort were white educated women. "Even though we know Black Americans and Latinx individuals got very sick with COVID-19, we did not see them in the long haulers clinic," notes Chemali who emphasizes this finding likely follows from disparity in healthcare with inability to find time and access to the care needed.

The post-COVID-19 long haulers clinic quickly became the launching base to advance the NIH-funded RECOVER study with principal investigator Ingrid Bassett, MD, investigator in the hospital's Division of Infectious Diseases. The study is aims to understand how and why COVID-19 affects people differently.

"The most important question is what is it in a person's make-up that influences how they react to COVID-19 in a specific way and exhibit certain symptoms?" Chemali asks. "Why do some people get very sick, others do not, some become long haulers and why do some people never get COVID-19 at all?"

To date, approximately 200 patients have been referred from the MGH COVID-19 long haulers clinic to the RECOVER Study and other trials conducted at throughout the Mass General Brigham healthcare system.

"Everyone is still grappling with understanding long COVID," concludes Chemali, noting that similar symptoms are found in patients with other post-viral diseases, post-traumatic brain injury, concussive syndrome or the vaguely understood chronic fatigue syndrome. "From a neurocircuitry point of view, we see that frontal networks are the most vulnerable in the post-COVID-19 phase."

Chemali suggests that addressing ways to restore frontal neurocircuitry -; such as good quality sleep, alleviating pain and headaches, treating anxiety and depression, and targeting attention and executive functions -; as well as offering support and promoting self-care are the pillars of a good and sustainable recovery.

Source:
Journal reference:

Gutierrez-Martinez, L., et al. (2022) Post-Acute Sequelae of SARS-CoV-2 Infection: A Descriptive Clinical Study. Neuropsychiatry. doi.org/10.1176/appi.neuropsych.21070193.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Mucosal COVID-19 boosters outperform mRNA shots in preventing upper airway infections